Case Study of Precision Medicine Genetic Testing Industry

• Main Authors: LIANG, CHIA-WEI, 梁家韋
• Other Authors: WANG, KUEI-YUAN
• Format: Others
• Language: zh-TW
• Published: 2019
• Online Access: http://ndltd.ncl.edu.tw/handle/ak439t

碩士 === 亞洲大學 === 經營管理學系碩士在職專班 === 107 === The world has moved towards a new era of AI artificial intelligence. Big data has penetrated into all walks of life, bringing about technological changes, increasing efficiency, and improving scientific precision. The medical industry is also moving towards the AI era, and is accelerating the new era of precision medicine. The output value of the precision medicine market is about 38.786 billion US dollars in 2015, and it is estimated that it will grow to 98.254 billion US dollars in 2023. . Based on the current situation analysis and future development forecast of the precision medical industry, through in-depth interviews and analysis by case companies to understand the current situation of the industry and the trend of future development changes, the research purposes: 1. the analysis of the current situation of the precision medicine industry. 2. in-depth discussion of the case company business model. 3. develop the case strategy and operation policy of the case company. 4. the feasibility of expanding overseas business locations. The scope of this study is based on the top three market share companies in Taiwan's precision medicine industry. The results of the study are: 1. according to the BCG four-quadrant classification, it belongs to the star products in the four quadrants. 2. the case company's operation continued to grow, continued to develop new products, and increase market share. 3. adopt a joint venture program to increase the source of funds. 4. the layout of Southeast Asia and the mainland market.